Evidence map›Paper›PMID 32784396›Full record

ReviewInternational journal of molecular sciences2020

YRNAs and YRNA-Derived Fragments as New Players in Cancer Research and Their Potential Role in Diagnostics.

Kacper Guglas, Iga Kołodziejczak, Tomasz Kolenda, Magda Kopczyńska, Anna Teresiak, Joanna Sobocińska, Renata Bliźniak, Katarzyna Lamperska

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synthetic short RNA in cancer.Frontiers in oncology · 2026
    Review
  6. Y-box binding proteins in immunity and RNA virus infection.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kacper GuglasLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Iga KołodziejczakPostgraduate School of Molecular Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
Tomasz KolendaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Magda KopczyńskaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznań, Poland.ORCID 0000-0002-7080-750X
Anna TeresiakLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Joanna SobocińskaDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
Renata BliźniakLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Katarzyna LamperskaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Poznan University of Medical Sciences · PLGreater Poland Cancer Center · PLMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

YRNAs are a type of short, noncoding RNAs. A total of four different transcripts can be distinguished, which are

Indexed as

Biomedical ResearchBiomarkers, TumorHumansNeoplasmsNucleic Acid ConformationPseudogenesRNA, Long NoncodingBiomarkers, TumorRNA, Long Noncodingbiomarkercancerpseudogenesshort noncoding RNAYRNAYRNA-derived fragments

Identifiers

PMID32784396
PMCPMC7460810
OpenAlexW3048223260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.